香港醫思醫療集團(02138.HK)中期純利減少74.7%至5330萬港元 中期息3港仙
格隆匯11月26日丨香港醫思醫療集團(02138.HK)發佈公告,截至2020年9月30日止6個月,公司收益7.97億港元,同比減少28.7%;期間溢利5330萬港元,同比減少74.7%;每股基本盈利為4.4港仙,宣派中期股息每股股份3.0港仙。
醫療保健服務為人們生活中不可或缺的一部分,因此對其的需求持續穩定增長。集團致力開設更多醫療專科,以滿足客户不斷增長的需求。醫療服務仍然是集團的主要增長動力。報告期內,醫療服務貢獻的收入為3.61億港元,較去年下半年增長20.3%,佔集團收入的45.3%。
截至2020年9月30日,包括公司在香港的兩家旗艦店及在中國大陸的12家診所在內,公司共經營60家診所及服務中心,所佔樓面面積合共約319,000平方尺,在香港、中國大陸及澳門共有118名全職專屬註冊醫生,涉及22個醫療專科服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.